Prevention of adverse reactions in therapy with high doses of lincomycin
Vacek, V.; Tesarová-Mágrová, J.; Stafová, J.
Arzneimittel-Forschung 20(1): 99-101
1970
ISSN/ISBN: 0004-4172 PMID: 5467452 Document Number: 28493
Document emailed within 1 workday
Related Documents
Astarita, C.; Franzese, A.; Sproviero, S.; Scala, G.; Ferrara, A.M.; Raucci, G.; Altucci, P. 1992: The epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. Nimesulide is tolerated by patients with adverse reactions to NSAIDs and modulates in man the skin response to histamine and codeine Recenti Progressi in Medicina 83(10): 567-571Casas, E.; Michán, A.; González Sanz, A.; García Puig, J. 1989: Prevention of adverse reactions to allopurinol Anales de Medicina Interna 6(1): 48
Sui, M.; Cui, L. 2017: Constructing a Gene-Drug-Adverse Reactions Network and Inferring Potential Gene-Adverse Reactions Associations Using a Text Mining Approach Studies in Health Technology and Informatics 245: 531-535
Kuefner, M.A.; Heinrich, M.; Bautz, W.; Uder, M. 2008: Suggestions for prevention of adverse reactions after intravasal administration of iodinated contrast media Rontgenpraxis; Zeitschrift für Radiologische Technik 56(6): 199-206
Li, G.-w. 2003: Be vigilant of the adverse reactions of glucocorticosteroids therapy Zhonghua Nei Ke Za Zhi 42(10): 678-679
Kubrik, N.E.; Zhurba, E.I. 1984: Adverse reactions to antibacterial therapy of tuberculosis Problemy Tuberkuleza 5: 66-67
Raininko, R.; Laivola, J.; Irjala, K. 1988: High dose brain CT with ioxaglate and diatrizoate adverse reactions and effects on urine protein tests European Journal of Radiology 8(1): 44-46
White Mediaceja, V.L.; Alfonso Fernández, L.A.; Ginard Cabañas, A.; Gómez Echevarría, A.H. 1995: Premedication for the prevention of adverse reactions to ionic iodized contrast media. Comparative study Revista Alergia Mexico 42(3): 45-48
Yoshikawa, T.T.; Nagami, P.H. 1982: Adverse drug reactions in TB therapy: risks and recommendations Geriatrics 37(7): 61-68
Glass, D.; Roffe, L.; Maini, R.N.; Wraith, D.G.; Nuki, G. 1975: Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity Clinical and Experimental Immunology 20(1): 55-63
Kruszewski, J.; Zaraś, E. 1994: Effect of cetirizine therapy on the rate of adverse reactions to specific desensitization Polski Tygodnik Lekarski 49(14-15): 337-340
Katricheva-Loginova, L.V.; Kaganova, T.I. 1985: Variants of the adverse reactions to infusion therapy in premature infants and their diagnosis Pediatriia 9: 29-33
Kromann-Andersen, H. 1987: Adverse reactions during salazosulfapyridine (sulfasalazin) therapy in Denmark 1968-1987 Ugeskrift for Laeger 149(52): 3557-3559
Bollea, M.R.; Floridia, M. 1988: Adverse reactions to food. Notes on physiopathology, clinical features and therapy La Clinica Terapeutica 126(5): 317-328
Jamali, J.; Dayo, A.; Adeel, A.; Qureshi, Y.; Khan, T.; Begum, S. 2018: A survey on gastrointestinal adverse drug reactions of Doxorubicin and Cyclophosphamide combination therapy JPMA. Journal of the Pakistan Medical Association 68(6): 926-928
Huber, M.; Stahlmann, R. 2012: The eye as target of adverse ocular drug reactions. Focus on systemic antiinfective therapy Medizinische Monatsschrift für Pharmazeuten 35(12): 436
Onoya, D.; Hirasen, K.; van den Berg, L.; Miot, J.; Long, L.C.; Fox, M.P. 2018: Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa Drug Safety 41(12): 1343-1353
Richter, J.M.; Colditz, G.A.; Huse, D.M.; Delea, T.E.; Oster, G. 1989: Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy American Journal of Medicine 87(3): 278-284
van Groeningen, C.J.; Gall, H.E.; Simons, K.A.; van Loenen, A.C.; Knobf, M.K.; Nauta, J.; Vermorken, J.B.; Pinedo, H.M. 1989: Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis Netherlands Journal of Medicine 35(5-6): 283-294
Homma, M. 1992: Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event Ryumachi 32(5): 429-431